OWA
WST icon

Opal Wealth Advisors’s West Pharmaceutical WST Stock Holding History

Opal Wealth Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.6K Buy
+126
New +$31.4K 0.01% 487
2025
Q3 		– Sell
-226
Closed -$49.4K – 560
2025
Q2 		$49.4K Sell
226
-11
-5% -$2.35K 0.01% 378
2025
Q1 		$53.1K Buy
+237
New +$65.3K 0.02% 352
2024
Q3 		– Sell
-194
Closed -$63.9K – 1178
2024
Q2 		$63.9K Buy
194
+8
+4% +$2.83K 0.02% 328
2024
Q1 		$73.6K Buy
+186
New +$68.8K 0.03% 200

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Opal Wealth Advisors's WST Position: Q1 2026 in Review

Opal Wealth Advisors opened a new position in West Pharmaceutical (WST) in Q1 2026: 126 shares worth $31.6K. The stake represents 0.01% of the portfolio and ranks #487 among its holdings. This is a return to the name: Opal Wealth Advisors previously reported a position in WST as recently as Q2 2025.

Opal Wealth Advisors first reported a position in WST in Q1 2024 and has held it in 5 quarters since. The position peaked at $73.6K in Q1 2024. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Opal Wealth Advisors held 126 shares of West Pharmaceutical worth $31.6K as of Q1 2026.
  • West Pharmaceutical was a new Opal Wealth Advisors position in Q1 2026.
  • West Pharmaceutical made up 0.01% of Opal Wealth Advisors's portfolio in Q1 2026, its #487 holding.
  • Opal Wealth Advisors first reported a position in West Pharmaceutical in Q1 2024 and has held it in 5 quarters since.
  • Opal Wealth Advisors's West Pharmaceutical position peaked at $73.6K in Q1 2024.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Opal Wealth Advisors's 13F filing for Q1 2026, filed 14 Apr 2026.